CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$79.71
-0.20 (-0.25%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-3.56%
1Y
+7.31%
YTD
+108.66%
Open$80.70
Previous Close$79.91
Day High$82.00
Day Low$77.38
52W High$91.00
52W Low$28.66
Volume—
Avg Volume1.05M
Market Cap8.58B
P/E Ratio181.19
EPS$0.35
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$53.13
Above
SMA 200
$69.00
Above
RSI (14)
26
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+28.4% upside
Current
$79.71
$79.71
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 681.22M | 550.53M | 785.70M |
| Net Income | 89.16M | 64.85M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 41.10M | 31.56M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |